4//SEC Filing
Aker Christopher Ray 4
Accession 0001209191-24-001874
CIK 0001505512other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:23 PM ET
Size
5.2 KB
Accession
0001209191-24-001874
Insider Transaction Report
Form 4
Aker Christopher Ray
Sr. VP & General Counsel
Transactions
- Sale
Common Stock
2024-01-18$1.19/sh−5,468$6,510→ 10,056 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001762611
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 8:23 PM ET
- Size
- 5.2 KB